KRT18 and cholangiocarcinoma: Interestingly, IDHs are also considered as proto-oncogenesin cancer metabolic derangement.42,54 These findingsadd novel mechanistic insights into the regulation of K18 and highlightthe potential to intervene in K18 O-GlcNAcylationas a therapeutic strategy against CCA tumorigenesis.